500087:BOM
Cipla Ltd
₹1,385.00
arrow_downward
-0.29%(-4.00) 1D
Sep 4, 3:30:00 PM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 500087...
Open
₹1,398.00
High
₹1,398.00
Low
₹1,375.85
Mkt. cap
1.12T
Avg. vol.
0.00
Volume
64.50K
Dividend
0.94%
Quarterly dividend
₹3.25
Ex-dividend date
Jun 5, 2026
P/E ratio
33.21
52-wk high
₹1,672.20
52-wk low
₹1,165.55
EPS
₹41.70
Shares outstanding
805.67M
No. of employees
31K
Open
₹1,398.00
High
₹1,398.00
Low
₹1,375.85
Mkt. cap
1.12T
Avg. vol.
0.00
Volume
64.50K
Dividend
0.94%
Quarterly dividend
₹3.25
Ex-dividend date
Jun 5, 2026
P/E ratio
33.21
52-wk high
₹1,672.20
52-wk low
₹1,165.55
EPS
₹41.70
Shares outstanding
805.67M
No. of employees
31K
News stories
From web sources and news partners
Business Standard
·
7 hours ago
Cipla inks exclusive partnership with Qilu Pharma for commercializing Pembrolizumab in US
Business Standard
·
12 hours ago
Cipla partners with Qilu to license, supply Keytruda biosimilar in US
TipRanks
·
1 day ago
Cipla Strikes Exclusive U.S. Deal for Keytruda Biosimilar with Qilu Pharmaceutical
TradingView
·
3 days ago
News by CNBC TV18 on TradingView, 2026-09-01 — cnbctv:d7d1bc073094b:0
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
About Cipla Ltd
CEOUmang Vohra
Employees31.4K
Founded1935
HeadquartersMumbai, Maharashtra, India
SectorPharmaceutical industry
Websitecipla.com